Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

Question 2

How does SHR-A1921 work, and what are its side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer clinical trial (NCT06394492). Contact the study team or your healthcare provider for specific answers.

What this study is about